Hetal Brahmbhatt, Thomas Guarinoni, Elizabeth Simmons
Hetal Brahmbhatt
Principal Investigator - Science and Technology Team, Pharma Services, Viral Vector
Services, Thermo Fisher Scientific
Dr Hetal Brahmbhatt is a Principal Investigator in the Science and Technology Team, Pharma
Services, Viral Vector Services at Thermo Fisher Scientific. She has a PhD in Biochemistry
and Biomedical Sciences from McMaster University where she characterized small molecule
modulators of apoptotic proteins. In her present role, she contributes to the development
of platform processes and technologies for the manufacturing of viral gene transfer vectors.
Elizabeth Simmons
Associate Director QC Analytics, Homology Medicines Inc
Beth has a Master’s degree from Lehigh University in Analytical Chemistry and Regulatory
Affairs with 13 years of industry experience. She has managed small and large Quality Control
laboratories including method transfer, qualification and validation teams in both small pharma
and CMO settings. During that time Beth has supported 2 facility start ups (Commercial
and Clinical) and managed technical teams focusing on small molecule, oligonucleotides, and
now gene therapy.
Thomas Guarinoni
Manager, Downstream Process team, Viralgen
Thomas Guarinoni, MSc was recruited in January 2017 as manager of the Downstream
Process team at Viralgen. He was successful in transferring the entire purification process
from Askbio to Viiralgen in record time. Thomas Guarinoni obtained his MSc in 2011 at
ENSTBB (National Superior College of Biotechnology) in Bordeaux, France.
